Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

News

The British Standards Institute has given CE Marking to Ventracor for its VentrAssist left ventricular assist device ...

Home December 18, 2006
Home
News

The FDA medical devices dispute resolution panel that met on Dec. 15 voted 3 to 1 to uphold a previous FDA decision that ...

Home December 17, 2006
Home
News

Two Illinois medical centers are now ready to use the TandemHeart PTVA System from CardiacAssist: Northwestern Memorial ...

Home December 17, 2006
Home
News

MicroMed Cardiovascular, Inc. has received a CE Mark extension to continue marketing its DeBakey VAD system in Europe ...

Home December 12, 2006
Home
News

The FDA will convene a Medical Device Dispute Resolution Panel (MDDRP) on Dec. 15 to consider the first device to ...

Home December 12, 2006
Home
News

Phase III of CoreValve’s international trial for its patented 18-French Revalving System is now one-third enrolled since ...

Home December 06, 2006
Home
News

The Third International Conference on Cell Therapy for Cardiovascular Diseases will convene Jan 17 to 19, at The ...

Home November 29, 2006
Home
News

An implantable technology to control high blood pressure in patients not responding to available medicines has ...

Home November 29, 2006
Home
News

In its third quarter financial report, San Diego-based Cytori said it has moved significantly closer to ...

Home November 20, 2006
Home
Feature | Ryan Hiett

If its cancer care, emergency medicine, pediatric and maternal-fetal medicine specialties keep Robert Wood ...

Home November 15, 2006
Home
News

CoreValve’s patented ReValving System, consisting of an 18-French delivery catheter, was used to percutaneously implant ...

Home November 12, 2006
Home
News

An initial review of the premarket approval application for the ATS 3f(R) Aortic Bioprosthesis Heart Valve has been ...

Home November 07, 2006
Home
News

CoreValve announced that its patented ReValving System, consisting of a 18F delivery catheter, was used to ...

Home October 23, 2006
Home
News

A test designed to measure the durability of CoreValve’s ReValving device reached 200 million cycles, the company ...

Home October 17, 2006
Home
Case Study

Our anesthesia department was searching for a more accurate means of assessing volume status and predicting the ...

Home October 05, 2006
Home
Subscribe Now